Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia

ClinicalTrials.gov ID: NCT02972658

Public ClinicalTrials.gov record NCT02972658. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer's Disease Dementia (Extension of Study AZES, The AMARANTH Study)

Study identification

NCT ID
NCT02972658
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
421 participants

Conditions and interventions

Interventions

  • Lanabecestat Drug

Drug

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 14, 2017
Primary completion
Oct 1, 2018
Completion
Oct 1, 2018
Last update posted
Dec 2, 2019

2017 – 2018

United States locations

U.S. sites
31
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Banner Alzheimer's Institute Phoenix Arizona 85006
Territory Neurology & Research Institute Tucson Arizona 85704
Pacific Research Network Inc San Diego California 92103
Mile High Research Center Denver Colorado 80218
Institute for Neurodegenerative Disorders New Haven Connecticut 06510
Georgetown University Medical Center Washington D.C. District of Columbia 20057
Brain Matters Research Delray Beach Florida 33445
Compass Research Orlando Florida 32806
IMIC, Inc. Palmetto Bay Florida 33157
Roskamp Institute Sarasota Florida 34243
Suncoast Neuroscience Associates St. Petersburg Florida 33713
Premiere Research Institute at Palm Beach Neurology West Palm Beach Florida 33407
The Multiple Sclerosis Center of Atlanta Atlanta Georgia 30327
University of Chicago Medical Center Chicago Illinois 60637
Community Clinical Research Center Anderson Indiana 46011
Boston Center for Memory Newton Massachusetts 02459
Hattiesburg Clinic Hattiesburg Mississippi 39401
Memory Enhancement Center of America, Inc. Eatontown New Jersey 07724
The Cognitive and Research Center of NJ Springfield New Jersey 07081
Advanced Memory Research Institute of New Jersey Toms River New Jersey 08755
Integrative Clinical Trials, LLC Brooklyn New York 11229
Columbia University Medical Center New York New York 10032
University of Rochester School of Medicine Rochester New York 14620
Valley Medical Primary Care Centerville Ohio 45459
Lindner Research Center Cincinnati Ohio 45219
Ohio State University Medical Center Columbus Ohio 43210
Lehigh Valley Hospital Allentown Pennsylvania 18103
Rhode Island Mood & Memory Research Institute East Providence Rhode Island 02914
Radiant Research Greer South Carolina 29651
Quillen College of Medicine, East TN State University Johnson City Tennessee 37604
The Memory Clinic Bennington Vermont 05201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02972658, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2019 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02972658 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →